StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMApr 28, 2026, 04:10 PM

CMMB Annual General Meeting Adjourned to May 5 Due to Lack of Quorum

AI Summary

Chemomab Therapeutics Ltd. announced the adjournment of its Annual General Meeting of Shareholders (AGM) from April 28, 2026, to May 5, 2026. The meeting was postponed due to a lack of quorum. The time and location for the rescheduled meeting remain unchanged. Further details regarding the proposed resolutions were previously provided in a proxy statement filed on March 20, 2026.

Key Highlights

  • Chemomab Therapeutics Ltd. (CMMB) Annual General Meeting (AGM) adjourned.
  • Original AGM date was April 28, 2026.
  • AGM rescheduled to Tuesday, May 5, 2026.
  • Adjournment due to a lack of quorum.
  • Meeting will be held at the same time and place.
  • Proxy statement with proposed resolutions filed March 20, 2026.